05/2024 – 05/2027, de la Roche (PI). CE Ref: DE–7580-20, A29143 – Technology Investment Funding Award (with contribution from CRUK Research Horizons). Pre-clinical development of engineered superkiller CAR-T cells targeting LGR5+ cancers.